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Abstract
Background: The presence of intraplaque haemorrhage (IPH) has been related to plaque rupture, is associated with
plaque progression, and predicts cerebrovascular events. However, the mechanisms leading to IPH are not fully
understood. The dominant view is that IPH is caused by leakage of erythrocytes from immature microvessels. The aim of
the present study was to investigate whether there is an association between atherosclerotic plaque microvasculature
and presence of IPH in a relatively large prospective cohort study of patients with symptomatic carotid plaque.
Methods: One hundred and thirty-two symptomatic patients with ≥2mm carotid plaque underwent cardiovascular
magnetic resonance (CMR) of the symptomatic carotid plaque for detection of IPH and dynamic contrast-enhanced
(DCE)-CMR for assessment of plaque microvasculature. Ktrans, an indicator of microvascular flow, density and leakiness,
was estimated using pharmacokinetic modelling in the vessel wall and adventitia. Statistical analysis was performed
using an independent samples T-test and binary logistic regression, correcting for clinical risk factors.
Results: A decreased vessel wall Ktrans was found for IPH positive patients (0.051 ± 0.011 min− 1 versus 0.058 ±
0.017 min− 1, p = 0.001). No significant difference in adventitial Ktrans was found in patients with and without
IPH (0.057 ± 0.012 min− 1 and 0.057 ± 0.018 min− 1, respectively). Histological analysis in a subgroup of patients that
underwent carotid endarterectomy demonstrated no significant difference in relative microvessel density between
plaques without IPH (n = 8) and plaques with IPH (n = 15) (0.000333 ± 0.0000707 vs. and 0.000289 ± 0.0000439, p = 0.585).
Conclusions: A reduced vessel wall Ktrans is found in the presence of IPH. Thus, we did not find a positive association
between plaque microvasculature and IPH several weeks after a cerebrovascular event. Not only leaky plaque
microvessels, but additional factors may contribute to IPH development.
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September 21, 2010).
NCT01709045, date of registration October 17, 2012. Retrospectively registered (first inclusion August 23, 2011).
Keywords: Atherosclerosis , DCE-MRI, Intraplaque hemorrhage, Microvasculature, Ischemic stroke, Cardiovascular Disease,
Magnetic Resonance Imaging (MRI), Cerebrovascular Disease/Stroke, Transient Ischemic Attack (TIA)
* Correspondence: eline.kooi@mumc.nl
1Department of Radiology and Nuclear Medicine, Maastricht University
Medical Centre, P.O. Box 5800, 6202, AZ, Maastricht, The Netherlands
2CARIM School for Cardiovascular Diseases, Maastricht University, Maastricht,
The Netherlands
Full list of author information is available at the end of the article
© The Author(s). 2019 Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0
International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and
reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to
the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver
(http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
Crombag et al. Journal of Cardiovascular Magnetic Resonance           (2019) 21:15 
https://doi.org/10.1186/s12968-019-0524-9
Background
Rupture of a vulnerable atherosclerotic plaque is very
likely to be an important cause of clinical ischemic
events such as stroke or myocardial infarction [1–3].
The presence of intraplaque haemorrhage (IPH) has
been identified as a key pathological factor that is associ-
ated with plaque rupture, plaque progression, and pre-
dicts cerebrovascular events [4–9]. The predictive value
of carotid IPH on cardiovascular magnetic resonance
(CMR) for cerebrovascular events was confirmed in sev-
eral meta-analyses [5–7], showing a hazard ratio of 5.7
(95% confidence interval of 3.0 to 10.9) [5]. However,
the pathophysiological origin of IPH is poorly under-
stood. The dominant view is that IPH originates from
erythrocytes that extravasate from plaque microvessels
into the plaque [10, 11]. These microvessels, mainly ori-
ginating from the adventitia, have poorly formed endo-
thelial cell junctions, making them prone to leakage of
erythrocytes and inflammatory cells into the plaque [10].
Neovessel sprouting from the lumen into the plaque tis-
sue has also been identified and could play a contribut-
ing role to IPH [12, 13]. Alternatively, it has been
suggested by us and others that plaque rupture/fissure is
important in the development of IPH [2, 14, 15]. Indeed,
recently we found that IPH occurs often in the proxim-
ity of fissures in the fibrous cap (FC) [16].
CMR has been established as the preferred imaging
method for non-invasive in vivo detection of IPH [17–19].
In addition, dynamic contrast-enhanced (DCE)-CMR has
emerged as a non-invasive method to assess carotid plaque
microvasculature. Quantitative pharmacokinetic DCE-CMR
parameters, in particular Ktrans (a reflection of the microves-
sel flow, density, and permeability), correlate well with the
extent of plaque microvasculature on histology as demon-
strated by ourselves and others [20–23]. In addition, it has
been shown that Ktrans can be determined with a good
inter-scan reproducibility (ICC of 0.79, p < 0.05 and coeffi-
cient of variation of 16% for the Patlak model) [23]. Since
CMR allows non-invasive assessment of IPH and plaque
microvasculature, it is uniquely suited to investigate the re-
lation between microvessels and IPH in patients.
DCE-CMR has also the advantage that Ktrans is not only
dependent on microvessel density, but also on plaque mi-
crovasculature flow and leakiness. Moreover, CMR allows
to study patients with a mild to moderate stenosis, who
rarely undergo carotid endarterectomy so that these plaques
are usually not available for histopathological studies. A re-
cent CMR study revealed a positive association between ad-
ventitial Ktrans and the presence of IPH within a group of 27
symptomatic patients with carotid plaque and varying de-
gree of stenosis [24]. These findings are in line with the
prevailing hypothesis that IPH originates from leaky
plaque microvasculature. However, confirmation of
these results in a larger patient group is needed.
The aim of the present study was to investigate
whether there is an association between the atheroscler-
otic plaque microvasculature and presence of IPH in a
relatively large prospective cohort study in symptomatic
patients with carotid plaque.
Materials and methods
Study population
In the present study, consecutive symptomatic patients
with a recent ischemic stroke/transient ischemic attack
(< 3 months) and a carotid plaque with a thickness of at
least 2–3 mm were considered for inclusion in a pro-
spective, observational imaging study. Degree of stenosis
was determined with clinically obtained Doppler ultra-
sound on the ipsilateral side.
Patient demographics and clinical risk factors were
collected during follow-up. Patients with a probable car-
diac source of embolism, clotting disorder, severe co-
morbidity, and standard contra-indications for CMR,
such as ferromagnetic/other electronic implants were
excluded. Patients with severe renal disease (estimated
glomerular filtration rate < 30 ml/min) were not eligible
for contrast-enhanced CMR and therefore excluded.
Approval of the local Institutional Ethical Review Board
was obtained and written informed consent was ob-
tained for all patients. The study was registered at Clini-
calTrials.gov under NCT01208025 and NCT01709045.
CMR imaging
CMR imaging was performed on a 3 T whole body CMR
system (Achieva, Philips Healthcare, Best, The
Netherlands) using a dedicated 8-channel carotid coil
(Shanghai Chenguan Medical Technologies Co., Shanghai,
China). A previously described multi-contrast CMR
protocol [25] was used to study plaque composition,
which included the following sequences: 3D time-of-flight
(TOF), 2D T1weighted (T1w) inversion recovery turbo
field echo (IR TFE), T2 weighted (T2w) turbo spin echo
(TSE) and pre-and post-contrast T1w quadruple inversion
recovery (QIR) TSE. The CMR protocol is listed in Table 1.
In short, the acquired and reconstructed resolution was
0.62mm× 0 .62–0.67mm and 0.30mm× 0.24–0.30mm,
respectively. For DCE-CMR, an end diastolic electrocard
iographically-gated 3D T1w-TFE CMR pulse sequence
was acquired centred at the position of the highest plaque
burden with the following parameters: repetition/echo
time 11.6/5.7ms, flip angle 35°, Field of View 130 × 130
mm, acquisition/reconstruction matrix 208 × 206/512 ×
512, five adjoining transversal slices with a slice thickness
of 2mm [26]. The temporal resolution was approximately
20 s per time frame (dependent on heart rate). At the be-
ginning of the third time frame, 0.1 mmol/kg of a small
molecular contrast agent (GBCA), Gadobutrol (Gadovist,
Bayer HealthCare, Berlin, Germany), was injected with a
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power injector (Spectris Solaris, Medrad, Warrendale,
Pennsylvania, USA) at 0.5 ml/sec followed by a 20ml sa-
line flush at the same rate. DCE-CMR acquisition was
continued for six minutes after contrast injection. Posi-
tioning of the center of the DCE-CMR slices at the pos-
ition with the highest plaque burden was done by visual
assessment by a trained researcher. Table 1 gives an over-
view of the used CMR sequences in this study.
CMR image review
Contours of the plaque and plaque components were
drawn on the ipsilateral side by a single experienced ob-
server as described previously, using dedicated vessel
wall analysis software (VesselMass, Leiden, the
Netherlands) [26]. In case of doubt, a second highly ex-
perienced observer was consulted. Both readers were
blinded for clinical characteristics and DCE-CMR test
results. Per slice, luminal and outer vessel wall contours
are annotated on the pre-contrast QIR T1w TSE images.
In case of artefacts in the pre-contrast images, the
post-contrast QIR T1w TSE, T1w TFE or T2w TSE are
used, subsequently. Normalized wall index (NWI), an in-
dicator of plaque burden, was calculated as total vessel
wall area divided by the sum of the luminal and vessel
wall area on the T1w QIR sequence. IPH was scored
present by trained readers if a hyperintense signal
(compared with the adjacent sternocleidomastoid muscle)
was observed on the T1w TFE or TOF images in the bulk
of the plaque, as previously described [25, 27, 28]. Fig. 1 il-
lustrates a plaque with IPH (Fig. 1a) as well as a plaque
without IPH (Fig. 1b). The lipid-rich necrotic core is also
delineated on the CMR images (by comparison of pre-
and post-contrast T1W QIR images; in case of absence of
post-contrast images, the T2w TSE images were used),
using previously published criteria [29–31]. On the
post-contrast T1w TSE image, the FC can be identified as
a high signal area between the lipid-rich necrotic core and
the lumen of the carotid artery [2]. The FC was dichoto-
mized according to previously published categorization
[12]. When a continuous high signal area between IPH
and the lumen was identified, FC status was classified as
being ‘thick and intact’. When no or an interrupted high
signal area was identified, FC status was classified as begin
‘thin and/or ruptured’.
DCE-CMR image review
Luminal and outer vessel wall contours were transferred
to the DCE-CMR images and for each time frame ad-
justment of these contours was deemed necessary when
small patient displacements had occurred during the dy-
namic acquisition. To avoid partial volume effects, lu-
minal contours were corrected by keeping sufficient
distance from the vessel lumen, as described in previous
studies [32]. When the adventitial vasa vasorum showed
hyperenhancement after contrast material administra-
tion, outer plaque contours were corrected to include
the adventitial vasa vasorum. The entire vessel wall re-
gion is defined as the region between the luminal and
outer wall contours. The adventitial region of the vessel
wall was delineated according to previously described cri-
teria, i.e. all pixels within 0.625mm of the outer wall con-
tour in a region of the vessel wall with plaque (defined as
having a wall thickness larger than 1.5mm) [24].
Carotid endarterectomy and histological preparation
Indication for carotid endarterectomy (CEA) was based
on the clinician’s decision. Surgeons were instructed to
remove the carotid plaque in one piece. Carotid end-
arterectomy specimens were collected after surgery and
histological processing was performed as described
Table 1 Carotid CMR scan parameters
Pulse sequence 3D TOF 3D T1w IR TFE T2w TSE Pre- and post-contrast T1w QIR TSE 3D T1w IR TFE (for DCE-CMR)
Acquisition plane transversal transversal transversal transversal transversal
TR (ms) 20 9.1 4800 800 11
TE (ms) 5 5.5 49 10 5.7
TI (ms) – 304 – 282 –
Flip angle (°) 20 15 – – 35
Number of slices 15 15 15 15 5
Slice thickness (mm) 2 2 2 2 2
FOV (mm) 160 × 160 160 × 128 160 × 160 160 × 160 130 × 130
Acquired matrix 260 × 258 260 × 204 260 × 252 260 × 240 208 × 206
Reconstruction matrix 528 × 528 528 × 528 528 × 528 528 × 528 512 × 512
ECG triggered No No No No Yes, end-diastolic
Fat suppression Yes Yes Yes Yes No
TOF time of flight, IR TFE inversion recovery turbo field echo, TSE turbo spin echo, QIR TSE quadruple inversion recovery turbo spin echo, TR repetition time,
TE echo time, TI inversion time, FOV field of view, ECG electrocardiogram
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previously [23]. In short, after CEA the carotid plaques
were immediately fixed in 10% buffered formalin, trans-
versely cut in 3-mm slices, decalcified, embedded in par-
affin, and cut in 4-mm (transverse) slices. Plaque
microvasculature was detected with immunohistochem-
istry using primary antibodies against CD31 (clone
JC70A, Dako North America, Carpinteria, California,
USA) for identification of endothelial cells. Plaque mi-
crovasculature was quantified on high spatial resolution
digital images by using morphometric analysis software
(QWin V3, Leica, Cambridge, United Kingdom). Plaque
microvasculature was measured as the CD31-positive
area surrounding a lumen. Relative density of microvessel
endothelium was calculated by dividing the total
CD31-positive area by the total plaque area. Fig. 2 illus-
trates a representative hematoxylin and eosin (HE) stain-
ing (demonstrating IPH) and the corresponding CD 31
staining (demonstrating microvessels in brown) from a pa-
tient without (Fig. 2a) and a patient with IPH (Fig. 2b).FC
integrity was defined as a disruption of the endothelial
layer and evidence of luminal thrombus formation at that
location, and was scored by 2 independent readers
Fig. 1 a Transversal cardiovascular magnetic resonance (CMR) images of a patient with carotid plaque in the right carotid artery with intraplaque
hemorrhage (IPH). The following CMR sequences were acquired: (A) pre-contrast T1-weighted (T1W) quadruple inversion recovery (QIR) turbo
spin echo (TSE), (B) post-contrast T1W QIR TSE, (C) time of flight (TOF), (D) T2W TSE and (E) T1W inversion recovery (IR) turbo field echo (TFE).
Three regional saturation slabs were positioned on T1W QIR TSE and T2W TSE sequences; one on the throat to reduce swallowing artefacts and
another two on the subcutaneous fat, with an angle of approximately 45 degrees with respect to the regional saturation slab that is positioned
on the throat (both left and right) to reduce ghosting. A lipid-rich necrotic core was identified as a region within the bulk of the plaque that
does not show contrast enhancement (* on B) on the post-contrast T1W QIR images. On the T1W IR TFE image, a hyper-intense signal in the bulk
of the plaque can be clearly observed, indicating the presence of IPH (* on panel E). Panel F shows the plaque contours on the post-contrast
T1W QIR TSE images (green = outer vessel wall, red = inner vessel wall, yellow = lipid-rich necrotic core, blue = IPH, orange/brown = calcifications).
b Transversal CMR image of a carotid plaque in the right carotid artery without IPH but with a small lipid-rich necrotic core. All panels consist of
the same sequences as in Fig. 1a
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(vascular biologists) with more than 15 years of experience
in carotid plaque scoring. The outcome of FC integrity
(intact or disrupted) was reported on the plaque level.
Data analysis
Pharmacokinetic modelling
Pharmacokinetic parameters were estimated using the
Patlak model [33] on a voxel-wise basis as previously de-
scribed [23] with a phase-based population averaged vas-
cular input function (VIF) determined in the carotid
artery [26]. Shortly, GBCA concentrations in the plaque
were calculated from the signal intensity time course by
using the Ernst equation based on literature values for the
longitudinal and transversal relaxation times of tissue [34]
and the r1 and r2 relaxation rates of contrast medium
(CM) [35] similar as in previous studies [23, 24, 36, 37].
Statistical analysis
For descriptive purposes, nominal and categorical vari-
ables are presented as absolute numbers and percentages
and continuous variables as mean with standard devi-
ation (if normally distributed) or as median with range
(if not normally distributed). Differences in proportions
between IPH positive and IPH negative patients were
tested for significance using the Chi square test. For test-
ing differences in continuous variables, such as vessel
wall Ktrans and adventitial Ktrans, the t-test for independ-
ent samples was used.
Multivariable linear regression analyses with vessel
wall Ktrans or adventitial Ktrans as dependent variable
were performed to adjust for differences in baseline
characteristics between IPH positive and IPH negative
patients. IPH (yes vs. no) and clinical risk factors with a
statistically significant association with IPH were entered
as independent variables. The regression coefficient cor-
responding with IPH group represents the adjusted
mean difference Ktrans values between IPH positive and
IPH negative patients.
P-values < 0.05 were considered to indicate statistical
significance. SPSS (version 23, International Business
Machines, Armonk, New York, USA) was used for the
statistical analyses.
Results
Patient characteristics
Within the present study, a total of 181 patients were
enrolled. Fifteen patients did not receive an CMR scan
(claustrophobia: n = 5, patient declined CMR: n = 3,
obesity: n = 2, ferromagnetic or other electronic im-
plants: n = 2, technical CMR problems: n = 1, patient re-
trieved informed consent: n = 1, exclusion because this
patient had no carotid plaque n = 1). In twenty five pa-
tients an DCE-CMR could not be performed due to ar-
rhythmias. Prior to analysis, nine additional patients
were excluded due to insufficient CMR image quality.
Hence, we could analyse the CMR data of 132 patients
(92 male, age: 69.5 ± 8.6 years). Clinical characteristics of
these patients are presented in Table 2. The CMR exam-
inations were performed at a median of 28 days with a
range of 2–215 days after the ischemic event. IPH was
detected in 54 (41%) patients. Histological specimens
were collected from 23 patients who underwent CEA.
Relative microvessel density could be calculated for all
23 patients, however FC integrity assessment was only
possible in 16/23 patients due to fragmentation of the
histological slides due to calcifications.
The association between IPH and plaque
microvasculature
Representative DCE-CMR images are presented in
Fig. 3.
Decreased mean Ktrans of the entire vessel wall was
found for patients with IPH (0.051 ± 0.011 min− 1)
compared to patients without IPH (0.058 ± 0.017 min− 1,
p = 0.001) (Fig. 4, Table 2). No difference was found for
mean adventitial Ktrans in plaques with and without IPH
(0.057 ± 0.017 min− 1 and 0.057 ± 0.018 min− 1, respect-
ively). Table 2 shows the differences in relevant baseline
characteristics between IPH positive and IPH negative
Fig. 2 a Hematoxylin and eosin (HE) staining (demonstrating the
absence of IPH) and the corresponding CD 31 staining (black arrows
show presence of microvessels) from a histological specimen
obtained during carotid endarterectomy. b Hematoxylin and eosin
(HE) staining (demonstrating IPH) and the corresponding CD 31
staining (no presence of microvessels) from a histological specimen
obtained during carotid endarterectomy, the black arrow points
towards the area were intraplaque hemorrhage is present
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patients. Males, current smokers, hypertensive patients,
and a higher NWI showed an positive association with
IPH. Adjustment for differences in sex, current smok-
ing, hypertension and NWI using multivariable linear
regression analysis resulted in an adjusted mean dif-
ference for vessel wall mean Ktrans of − 0.008 (95%
CI: -0.13-0.002, p = 0.007) and an adjusted mean dif-
ference for adventitial mean Ktrans of 0 (95% CI:
-0.007-0.007, p = 0.925), (Table 3).
Out of the 132 included patients, 59 had a thin or rup-
tured FC on CMR (44.7%). In the plaques with IPH, in
47 (90.4%) cases a thin or ruptured FC was identified,
while in the plaques without IPH only 12 (15.2%) pla-
ques had a thin or ruptured FC (p = 0.001).Histological
analysis demonstrated a relative microvessel density of
0.000333 ± 0.0000707 in the group of patients without
IPH (n = 8), and 0.000289 ± 0.0000439 (n = 15) in the
IPH positive group. This difference was not significant
(p = 0.585). Patients who had an intact endothelial layer
overlying the FC on histology (n = 9) showed higher
mean Ktrans values (vessel wall Ktrans: 0.054/min ± 0.003
versus 0.048/min ± 0.004; p = 0.243) adventitial Ktrans
(0.063/min ± 0.003 versus 0.050/min ± 0.003, p = 0.018)
compared to patients with a disrupted endothelial layer
overlying the FC. There was no significant difference in
microvessel density between patients with or without an
intact FC on histological specimens (0.00025 ± 0.00005
versus 0.00030 ± 0.00005, p = 0.522) (n = 16). There was
no significant association between presence of IPH on
CMR images and FC integrity assessed on the histo-
pathological specimens (Spearman 0.2, p = 0.463, n = 16).
Discussion
The present prospective imaging study in symptomatic
patients demonstrated a negative association between
vessel wall Ktrans, a measure of microvascular density,
flow and/or permeability, and the presence of IPH in ca-
rotid atherosclerotic plaques. There was no association
between adventitial Ktrans and the presence of IPH. We
could not confirm a positive association between (leaky)
adventitial microvasculature (Ktrans) and IPH.
Previously, several histopathological studies reported
a link between IPH and increased microvessel density
[38, 39]. However, this link was not present in all vascu-
lar beds and it was also demonstrated that plaques with
IPH with a low microvascular density are quite com-
mon. Derksen et al. [38] reported a significantly higher
percentage of plaques with increased microvessel dens-
ity in the presence of IPH (50% versus 42%) in 752 ca-
rotid endarterectomy specimens, however no difference
was found in 209 femoral endarterectomy plaque speci-
mens. Their study also demonstrated that 50% of the
carotid plaques with IPH had a low microvascular
density, showing that IPH also occurs frequently in pla-
ques with low microvascular density. McCarthy et al.
[39] observed significantly more microvessels in pla-
ques with IPH in a study of 28 carotid endarterectomy
specimens, but did not report quantitative data on the
Table 2 Patient characteristics
Subjects [n] (%) Total N = 132 (100) IPH present N = 54 (40.6) IPH absent N = 79 (59.4) p-value
Age [y] 69.5 ± 8.6 69.4 ± 8.8 69.6 ± 8.5 0.918
Male sex [n] (%) 69.2% 45 (83.3) 47 (59.5) 0.004
Body mass index [kg/m2] 26.7 ± 3.8 26.3 ± 3.0 27.0 ± 4.3 0.296
Currently smoking* [n] (%) 21.1% 8 (14.8) 20 (25.6) 0.015
Diabetes mellitus [n] (%) 18.0% 10 (18.5) 14 (17.7) 1.000
Hypertension [n] (%) 65.4% 43 (79.6) 44 (55.7) 0.005
Hypercholesterolemiaa [n] (%) 51.9% 32 (60.4) 37 (47.4) 0.158
Normalized wall index 0.32 ± 0.23 0.43 ± 0.18 0.24 ± 0.23 < 0.001
Statin use before most recent cerebrovascular event* [n] (%) 58.6% 35 (66) 43 (54.4) 0.209
Time between event and MRI [days] (range) 28 (2–215) 22.5 (2–215) 34 (3–122) 0.676
Degree of stenosis
mild (0–29%) 0.8% 0 1 (1.3) 0.056
moderate (30–69%) 66.2% 30 (55.6) 58 (73.4)
severe (> 70%) 31.6% 22 (40.7) 20 (25.3)
occlusion 1.5% 2 (3.7) 0
Vessel wall K trans (/min) 0.055 ± 0.015 0.051 ± 0.011 0.058 ± 0.017 0.001
Adventitia K trans (/min) 0.057 ± 0.018 0.057 ± 0.017 0.057 ± 0.018 0.980
*Data known for 131 out of 132 patients. a Data known for 130 out of 132 patients
Data are presented as mean ± standard deviation or n (%)
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increase in plaque microvasculature. Gössl et al. [40]
studied microvasculature in 15 hearts, obtained from
autopsy and found a positive (Kendall-Tau beta rank)
correlation between microvessel density in the coronary
vessel wall and glycophorin A score (histological stain-
ing for erythrocyte fragments) of 0.65 (p < 0.01). It
should be noted that also normal vessel wall segments
with typically a low glycophorin A score and a low mi-
crovasculature density were included in their data ana-
lysis, which may have affected the correlation. A recent
histopathological study described a non-lipid driven
process in which alternative (M2) macrophages pro-
mote plaque progression. They demonstrated signifi-
cantly increased microvessels per unit in areas
containing high CD163, a marker of M(Hb) macro-
phages, suggesting a relation with plaque angiogenesis
[41]. Another reason why our results differ from histo-
pathological studies might lay in the difference of how
microvasculature was measured. The DCE-CMR par-
ameter Ktrans does not only reflect the microvascular
density, but also microvascular flow and leakiness,
while in histopathological studies the microvascular
density is measured.
Scoring of IPH presence on CMR images has been
proven to be an accurate method to identify IPH presence
and has been validated with histopathology [17–19, 27].
Reproducibility of the pharmacokinetic variables has been
Fig. 3 Pre-contrast T1 weighted (T1w) quadruple inversion recovery (QIR) turbo spin echo (TSE) image (a) from a patient with intraplaque
hemorrhage (IPH). Note that a Regional Saturation Technique (REST) slab is visible on the right side, which was placed over the subcutaneous fat
tissue to prevent ghosting artefacts. Three-dimensional T1w inversion recovery turbo field echo (IR TFE) image (b) from the same patient with
IPH. A hyperintense signal is visible within the bulk the plaque compared with the adjacent sternocleidomastoid muscle (*), indicating the
presence of IPH. Parametric Ktrans map of the plaque is overlaid on IR TFE image shown in B (c). In this parametric map voxelwise determined
Ktrans values are colour encoded from 0 to 0.25 min− 1. Within this plaque, the IPH exhibits low Ktrans values, shown in dark red, while higher Ktrans
values (brighter red) are observed in the outer vessel wall (adventitial layer). Pre-contrast T1w QIR TSE image from a patient without IPH (d). 3D
T1w IR TFE image (e) from the same patient without IPH. Parametric Ktrans map is overlaid on IR TFE image shown in B (f). In this parametric map
voxelwise determined Ktrans values are colour encoded from 0 to 0.25 min− 1. Within this plaque, higher Ktrans values are observed, shown in
bright red/yellow/white. Written informed consent for publication of their clinical details and/or clinical images was obtained from the patients. A
copy of the consent forms is available for review by the Editor of this journal
Fig. 4 Vessel wall and adventitial Ktrans versus IPH status. Vessel wall
and adventitial Ktrans (mean ± standard error) for patients with (IPH+)
and without intraplaque haemorrhage (IPH-)
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validated in animals, using different contrast media and in
patients, showing correlation between Ktrans and micro-
vessel density on histological slices [23, 42–44]. Sun et al.
found an increased adventitial Ktrans when IPH was
present in a study of 27 symptomatic patients with carotid
plaque, while we found no difference in adventitial Ktrans
between plaques with and without IPH in our study of
132 patients [24]. Our analysis differed from this previous
study because Sun et al. studied the maximum value of
mean Ktrans across all slices, which represents microvascu-
lar hotspots in the adventitia. A sub-analysis of the 75th
percentile value of the Ktrans distribution in the adventitial
region in the present study, which is also indicative for
hotspots of leaky microvessels, confirmed the lack of a sig-
nificant difference in adventitial Ktrans plaques with and
without IPH. We also looked at Ktrans of the entire vessel,
since IPH is located in the bulk of the plaque. We found
lower mean Ktrans values in the entire vessel wall in pa-
tients with IPH. The lower values of Ktrans in the entire
vessel wall may be due to an increased amount of necrotic
tissue and thus a decreased microvessel density in plaques
with IPH. Indeed, a significant negative Pearson’s correl-
ation coefficient (ρ = − 0.20, p = 0.021) was found for mean
vessel wall Ktrans with the lipid-rich necrotic core (LRNC)
volume. These results indicate a decrease of the athero-
sclerotic plaque microvasculature in plaques with a larger
LRNC. In the aforementioned study of Sun et al., the time
interval between carotid CMR and the most recent event
was 16.3 ± 18.7 days whereas in the present study this time
interval was 34.8 ± 23.3 days. A sub analysis within our
study of patients in the group with a time interval below
the median (≤28 days, mean 17.4 ± 7.4 days) showed also
no significant difference in adventitial Ktrans between IPH
positive and IPH negative plaques.
The prevailing hypothesis is that IPH originates from
leakage of erythrocytes out of immature microvessels
into the atherosclerotic plaque tissue [10]. The present
study could not confirm increased microvasculature in
plaques with IPH of recently symptomatic patients. In
fact, we observed the opposite effect, possibly related to
a larger amount of necrotic tissue in plaques with IPH.
Additional processes may thus contribute to IPH. It has
already been suggested that disruptions of the fibrous
cap (e.g. plaque fissures or plaque rupture) can lead to
IPH [45]. A histopathological study [14] showed that FC
fissures were frequently accompanied by IPH. In line
with the concept that IPH can also originate from FC
disruption, it was recently shown that the presence of
intraplaque haemorrhage is associated with a disruption
of the atherosclerotic plaque surface (plaque ulceration
and/or a fissured FC) in patients with a mild to moder-
ate carotid stenosis [15]. The CMR results of the present
study also demonstrated a higher prevalence of a thin or
ruptured FC in patients with IPH. Together these find-
ings support that disruptions of the FC may contribute
to IPH [15]. The lack of association that was found in the
present study between IPH and FC integrity and micro-
vascular density as assessed on the histopathological spec-
imens may be due to the limited sample size, since only a
limited number of patients was scheduled for carotid end-
arterectomy. Furthermore, the technique used in our
study (DCE-CMR) not only looks at microvessel density,
like histopathological analysis, but also takes into account
flow and leakiness of the microvessels.
Another important factor in the formation of IPH might
be plaque biomechanics. This is supported by several find-
ings in literature. Firstly, a recent study in 80 asymptom-
atic subjects with a 16–79% carotid stenosis showed low
diastolic blood pressure to be associated with IPH [46].
Additionally, pulse pressure, which may be considered as
driving force for plaque deformation during the cardiac
cycle, has been identified as a strong determinant of IPH
in 80 human carotid specimens from both symptomatic
and asymptomatic patients [47]. Secondly, in histopatho-
logical studies IPH occurs more frequently in the up-
stream region of the plaque, where the blood pressure is
much higher, due to pressure wave reflection [48]. Thirdly,
computational models have shown IPH to be associated
with higher structural wall stress [49]. Finally, a recent
study from Lin et al. showed an association between IPH
and plaque surface calcification, [50] that has been shown
to lead to a local increase in biomechanical stress [51].
Apart from a lower vessel wall Ktrans, presence of IPH
was positively associated with NWI (indicative for
plaque burden). This is in line with previous work, that
demonstrated IPH to be associated with wall thickness,
plaque length [46], and plaque progression [9, 52–54].
Due to the relatively small size of carotid plaques, a
high spatial resolution of DCE-CMR is crucial, limiting
the temporal resolution. Accurate determination of the
first pass peak of the VIF is not possible with the high
spatial resolution CMR pulse sequence. Therefore,
within the current study a previously determined popu-
lation averaged VIF was used. Several studies showed
Table 3 Results of the univariate and multivariate regression analysis
Univariate Multivariate
Regression coefficient for IPH 95% CI p-value Regression coefficient for IPH 95% CI p-value
Mean vessel wall Ktrans -0.007 −0.13 - -0.002 0.005 −0.008 −0.013 - 0.002 0.007
Mean adventitial Ktrans 0 −0.006 - 0.007 0.919 0 −0.007 - 0.007 0.925
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that the use of this population averaged, phase-based
VIF is accurate and correlates with microvessel density
on histological slices [23, 26, 55, 56].
Scoring of IPH presence on T1-weighted IR TFE CMR
images, also known as MP-RAGE images, has proven to
be an accurate method to identify IPH presence and has
been validated with histopathology by us and others
(specificity > 86%, sensitivity ≥80%) [17, 57]. The degrad-
ation of haemorrhage into methemoglobin results in T1
shortening and correspondingly causes a high signal inten-
sity on T1-weighted CMR images [58]. Methemoglobin is
particular present in fresh and recent intraplaque haemor-
rhage. Therefore, we cannot exclude that lesions have
been classified as IPH negative despite having old IPH.
However, previous work from our group has shown that
in a similar patient population (stroke patients with ipsi-
lateral < 70% carotid stenosis) the hyperintense signal on
IR TFE images is very persistent in time [59]. Out of 92 in-
cluded patients, a hyperintense signal in the bulk of the
plaque on T1w IR TFE CMR images was detected in 20
patients at baseline. One year later, the hyperintense signal
was still present in 16 of these 20 patients.Development of
the plaque microvasculature is a dynamic process, which
is thought to be related to inflammation in the plaque tis-
sue [36, 60, 61]. Increased activity of macrophages within
the plaque tissue is associated with hypoxia and subse-
quent angiogenic stimuli [62, 63] can result in the forma-
tion of new microvessels. Previous research has shown
that the presence of IPH does not change significantly
over a period of up to 1.5 years [53, 54, 64]. This suggest
that IPH is either a continuous process or haemoglobin,
which produces the hyperintense signal on IR TFE CMR,
is entrapped within the atherosclerotic plaque for a long
time period. The findings of the present study indicate
that there is no continuous leakage of erythrocytes from
plaque microvasculature several weeks after an ischemic
event, since we found no increase in Ktrans in plaques with
IPH at this time point. It cannot be excluded that IPH and
the resulting healing process after the bleeding can lead to
a reduction in plaque microvasculature.
Conclusions
In this DCE-CMR study of symptomatic carotid athero-
sclerosis, we found an inverse association between IPH
and vessel wall Ktrans (indicative for microvascular flow,
density, and leakiness). This indicates that no on-going
leakage of erythrocytes from plaque microvasculature
occurs in plaques with IPH several weeks after a cere-
brovascular event. This is not in line with the dominant
view that IPH develops as a consequence of leaky micro-
vasculature. Additional factors, such as a disrupted
plaque surface, may contribute to the development of
IPH. Further longitudinal studies are warranted to un-
ravel underlying mechanisms contributing to IPH.
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